Current concepts in the immunopathogenesis of psoriasis

被引:49
作者
Lowes, MA
Lew, W
Krueger, JG
机构
[1] Rockefeller Univ, New York, NY 10021 USA
[2] Yonsei Univ, Coll Med, Yongdong Severance Hosp, Dept Dermatol, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Yongdong Severance Hosp, Cutaneous Biol Res Inst, Seoul, South Korea
关键词
D O I
10.1016/j.det.2004.03.010
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
There is much evidence to support the concept that psoriasis is a type 1 autoimmune disease, primarily mediated by interferon gamma and other inflammatory cytokines. There has been renewed interest in the role of components of the innate immune system, however, and it may be that overlap between the innate and acquired arms of the immune system can better explain immunopathogenesis in psoriasis. Relevant cell types, receptors, and immune mediators within these traditional boundaries of the immune system are discussed. Finally, pathogenic contributions from important psoriatic mouse models and recent genomic data using the new gene chip technology are elaborated.
引用
收藏
页码:349 / +
页数:22
相关论文
共 157 条
[31]  
Curry JL, 2003, ARCH PATHOL LAB MED, V127, P178
[32]  
Debets R, 1997, J IMMUNOL, V158, P2955
[33]   ENHANCED PRODUCTION OF BIOLOGICALLY-ACTIVE INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA BY PSORIATIC EPIDERMAL-CELLS EX-VIVO - EVIDENCE OF INCREASED CYTOSOLIC INTERLEUKIN-1-BETA LEVELS AND FACILITATED INTERLEUKIN-1 RELEASE [J].
DEBETS, R ;
HEGMANS, JPJJ ;
TROOST, RJJ ;
BENNER, R ;
PRENS, EP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) :1624-1630
[34]   Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses -: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease [J].
Deguchi, M ;
Aiba, S ;
Ohtani, H ;
Nagura, H ;
Tagami, H .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2002, 294 (07) :297-302
[35]   CD40 is functionally expressed on human keratinocytes [J].
Denfeld, RW ;
Hollenbaugh, D ;
Fehrenbach, A ;
Weiss, JM ;
vonLeoprechting, A ;
Mai, B ;
Voith, U ;
Schopf, E ;
Aruffo, A ;
Simon, JC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) :2329-2334
[36]   OVEREXPRESSION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS IN PSORIASIS [J].
DETMAR, M ;
BROWN, LF ;
CLAFFEY, KP ;
YEE, KT ;
KOCHER, O ;
JACKMAN, RW ;
BERSE, B ;
DVORAK, HF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :1141-1146
[37]   KERATINOCYTE-DERIVED VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IS A POTENT MITOGEN FOR DERMAL MICROVASCULAR ENDOTHELIAL-CELLS [J].
DETMAR, M ;
YEO, KT ;
NAGY, JA ;
VANDEWATER, L ;
BROWN, LF ;
BERSE, B ;
ELICKER, BM ;
LEDBETTER, S ;
DVORAK, HF .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (01) :44-50
[38]   Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1(+++), MS-1(+/-), 25F9(-)) in psoriatic dermis [J].
DjemadjiOudjiel, N ;
Goerdt, S ;
Kodelja, V ;
Schmuth, M ;
Orfanos, CE .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1996, 288 (12) :757-764
[39]   OVEREXPRESSION OF TRANSFORMING GROWTH FACTOR-ALPHA IN PSORIATIC EPIDERMIS [J].
ELDER, JT ;
FISHER, GJ ;
LINDQUIST, PB ;
BENNETT, GL ;
PITTELKOW, MR ;
COFFEY, RJ ;
ELLINGSWORTH, L ;
DERYNCK, R ;
VOORHEES, JJ .
SCIENCE, 1989, 243 (4892) :811-814
[40]   GROWTH-FACTOR AND PROTOONCOGENE EXPRESSION IN PSORIASIS [J].
ELDER, JT ;
KLEIN, SB ;
TAVAKKOL, A ;
FISHER, GJ ;
NICKOLOFF, BJ ;
VOORHEES, JJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (05) :S7-S9